MARKET WIRE NEWS

Outperform Recommendation Issued On MIRM By RBC Capital

Source: KlickAnalytics

2026-02-17 16:15:03 ET

  • RBC Capital analyst issues OUTPERFORM recommendation for MIRM on February 17, 2026 09:23PM ET.
  • MIRM was trading at $102.83 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 1 - Strong Buy, 15 - Buy recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations

    Full story available on KlickAnalytics.com
    Mirum Pharmaceuticals Inc.

    NASDAQ: MIRM

    MIRM Trading

    0.46% G/L:

    $90.25 Last:

    202,111 Volume:

    $90.13 Open:

    mwn-ir Ad 300

    MIRM Latest News

    MIRM Stock Data

    $5,184,583,745
    44,013,457
    0.43%
    119
    N/A
    Biotechnology & Life Sciences
    Healthcare
    US
    Foster City

    Subscribe to Our Newsletter

    Link Market Wire News to Your X Account

    Download The Market Wire News App